ArticleCureus2025
Breaking the Paradigm: Successful Treatment of Rare CD4/CD8 Dual-Positive, Advanced Mycosis Fungoides Using CHOP Therapy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycosis fungoides (MF) is one of the most important representatives of cutaneous T-cell lymphomas. This disease is rare, and the diagnosis always requires a clinical-pathological correlation. The prognosis depends on its stage and is usually favorable when found in early stages. CD4/CD8 duality is an uncommon immune phenotype. We are presenting a successful treatment of a case of dual-positive MF in the third stage. The simultaneous expression of CD4 and CD8 in skin lesions has been suggested to potentially indicate an improved clinical outcome in patients with MF. Patient was treated with the CHOP regimen and a combination of symptomatic therapies, which resulted in a favorable therapeutic response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.